Is Zimmer Biomet Holdings, Inc. (ZBH) A Good Stock To Buy Now?
Is ZBH a good stock to buy? We came across a bullish thesis on Zimmer Biomet Holdings, Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on ZBH.
Zimmer Biomet Holdings Inc. (ZBH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | GAMCO Investors Mario Gabelli | 228,658 | $19,685,167 | -2% | 0.18% |
| 2. | Levin Easterly Partners John Murphy | 161,354 | $13,890,966 | +113% | 0.71% |
| 3. | Hourglass Capital Kenneth A. Moffet | 72,315 | $6,225,598 | -8% | 1.22% |
| 4. | Walleye Capital Will England | 37,861 | $3,259,453 | +596% | 0.01% |
| 5. | Skylands Capital Charles Paquelet | 14,711 | $1,266,470 | +14% | 0.16% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $104.75 | 2,135 | $223,641.25 | 4,060 | 2023-11-09 | Filing | |
| $117.11 | 1,000 | $117,114.00 | 3,540 | 2023-08-28 | Filing | |
| $120.37 | 1,000 | $120,370.00 | 1,000 | 2023-08-30 | Filing | |
| $116.48 | 2,000 | $232,960.00 | 4,000 | 2023-08-28 | Filing | |
| $115.50 | 1,300 | $150,150.00 | 3,385 | 2023-08-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $82.66 | 800 | $66,128.00 | 27,251 | 2026-05-29 | Filing | |
| $82.64 | 4,200 | $347,088.00 | 28,051 | 2026-05-29 | Filing | |
| $94.66 | 2,650 | $250,849.00 | 10,224 | 2026-03-12 | Filing | |
| $96.49 | 1,000 | $96,490.00 | 17,670 | 2026-02-12 | Filing | |
| $103.59 | 1,200 | $124,302.00 | 18,584 | 2025-09-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 15,614,847 | $1,344,282,175 | 0.02% | |
| 2. | 12,183,614 | $1,048,887,329 | 0.22% | |
| 3. | 8,877,171 | $766,342,640 | 0.02% | |
| 4. | 5,349,223 | $458,747,478 | 0.02% | |
| 5. | 2,744,463 | $236,270,951 | 0.1% |
News See All
Is Zimmer Biomet Holdings (ZBH) One of the Best Robotic Surgery Stocks to Buy?
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the best robotic surgery stocks to buy. Canaccord cut the price target on Zimmer Biomet Holdings, Inc.
7 Best Robotic Surgery Stocks to Buy
On May 20, Todd Sohn, Strategas Securities, appeared on CNBC’s ‘Power Lunch’ to discuss how investors should view the equity markets.
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q1 2026 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet First Quarter 2026 Earnings Conference Call. [Operator Instructions].
10 Stocks Reeling From Huge Losses
Zimmer Biomet fell to a new 13-year low on Tuesday, slashing 10.53 percent to close at $82.84 apiece despite posting a strong earnings performance in the first quarter, as investors were rattled by the...
Leerink Sees Limited Near-Term Upside for Zimmer Biomet Holdings, Inc. (ZBH) Ahead of 2027 Catalysts
TheFly reported on April 13 that Leerink Partners began coverage of ZBH with a Market Perform rating and a $10 price target.
10 Best Healthcare Stocks to Buy and Hold for 3 Years
The first quarter of this year has seen a great deal of volatility in the equity markets. The S&P 500 fell into correction territory before rising again after first soaring to all-time highs.
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q4 2025 Earnings Call Transcript
Operator: Please stand by. Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Fourth Quarter 2025 Earnings Conference Call.
Zimmer Biomet Holdings (ZBH)'s 2026 Expectations Remain Cautious Amid Internal Reset
On January 13, 2026, Zimmer Biomet Holdings, Inc. (NYSE:ZBH) laid out cautious expectations for 2026 at the 44th Annual J.P. Morgan Healthcare Conference, according to The Fly.
10 Undervalued Wide Moat Stocks to Buy Right Now
As U.S. markets go further into 2026, they are witnessing a shift in the macro backdrop that is reshaping expectations across asset classes. Following a sluggish 2025, U.S.
Hedge Fund Resource Center